Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma
- 1 January 1999
- journal article
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 10 (1) , 55-66
- https://doi.org/10.1016/s1044-0305(98)00118-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Microsample Determination of Lovastatin and its Hydroxy Acid Metabolite in Mouse and Rat Plasma by Liquid Chromatography/Ionspray Tandem Mass SpectrometryJournal of Mass Spectrometry, 1997
- Quantitation of SR 27417 in human plasma using electrospray liquid chromatography-tandem mass spectrometry: A study of ion suppressionJournal of the American Society for Mass Spectrometry, 1996
- Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemiaJAMA, 1996
- Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.1996
- Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase InhibitorArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Simultaneous determination of tenidap and its stable isotope analog in serum by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometryJournal of Mass Spectrometry, 1992
- Determination of SQ 33,600, a phosphinic acid containing HMG CoA reductase inhibitor, in human serum by high-performance liquid chromatography combined with ionspray mass spectrometryJournal of Mass Spectrometry, 1992
- Rapid determination of methandrostenolone in equine urine by isotope dilution liquid chromatography-tandem mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1989